Charles River Laboratories | Себестоимость



Cost Of Sales Изменить Дата
Agilent USD 782M 2M 2025-01
Align Technology USD 298.28M 2.18M 2024-12
Bio-Rad Laboratories USD 312.4M 18.57M 2024-12
Bruker USD 486.3M 40.7M 2024-12
Cardinal Health USD 53.32B 2.95B 2024-12
Charles River Laboratories USD 682.87M 40.87M 2024-12
Cigna USD 59.19B 2.1B 2024-12
CVS Health USD 84.81B 1.94B 2024-12
Danaher USD 2.65B 251M 2024-12
Dentsply International USD 450M 6M 2024-12
Elevance Health 33.5B 551M 2024-12
Galapagos EUR 112.93M 112.91M 2024-12
Hologic USD 441.3M 11M 2024-12
Humana 25.38B 24.75B 2024-12
Illumina USD 376M 41M 2024-12
Incyte USD 82.38M 2.49M 2024-12
IQVIA Holdings USD 2.58B 62M 2024-12
Laboratory Of America USD 2.43B 55.5M 2024-12
Lonza CHF 1.94B 858M 2024-06
McKesson USD 92.04B 1.64B 2024-12
Merck EUR 2.12B 3M 2024-09
Mettler Toledo International USD 405.81M 548.72M 2024-12
Novartis USD 3.32B 90M 2024-12
Pfizer USD 5.65B 781M 2024-12
Quest Diagnostics USD 1.76B 91M 2024-12
Revvity USD 317.08M 17.85M 2024-12
Thermo Fisher Scientific USD 6.57B 303M 2024-12
United Therapeutics USD 75.9M 7.2M 2024-12
UnitedHealth 79.5B 1.71B 2024-12
Walgreens Boots Alliance USD 32.68B 1.39B 2024-11
Waters USD 348.52M 46.86M 2024-12
West Pharmaceutical Services USD 475.2M 7M 2024-12



Charles River Laboratories Себестоимость - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2025.